thiorphan has been researched along with telmisartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaikwad, AB; Malek, V | 1 |
| Gaikwad, AB; Malek, V; Sankrityayan, H; Sharma, N | 1 |
2 other study(ies) available for thiorphan and telmisartan
| Article | Year |
|---|---|
Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy.
Topics: Acetylation; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Drug Therapy, Combination; Fibrosis; Histone Acetyltransferases; Histones; Male; Myocytes, Cardiac; Neprilysin; Protease Inhibitors; Protein Processing, Post-Translational; Rats, Wistar; Signal Transduction; Telmisartan; Thiorphan; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diminazene; Fibrosis; Inflammation; Kidney; Male; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin-Angiotensin System; Streptozocin; Telmisartan; Thiorphan | 2019 |